close menu

For Families & Caregivers

Patient Stories

Prostate Cancer and Genomic Testing

More than 50% of prostate cancer is low-risk. These survivor stories detail how genomic testing helped determine the treatment plan that was right for them.


Jim: Prostate Cancer Survivor Shares His Story

Jim and his doctor used the Oncotype DX Genomic Prostate Score to determine that active surveillance was the best course of treatment for his prostate cancer.


Buddy: Prostate Cancer Survivor Shares His Story

Buddy and his doctor used genomic testing to form a treatment plan for his low-risk prostate cancer.


Greg: Prostate Cancer Survivor Shares His Story

After multiple medical opinions, Greg turned to genomic testing to discover his prostate cancer was non-aggressive.